Dr Dana Rizk discusses Voyxact (sibeprenlimab-szsi), a new FDA-approved treatment to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression. Dr ...
This press release from Healthy Kidney Inc. highlights their 2 Part Video Series on How to Lower Proteinuria in CKD Patients, focusing on dietary changes. One of the most effective ways to manage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results